pf-06823859
Showing 1 - 4 of 4
Lupus Erythematosus, Systemic, Lupus Erythematosus, Cutaneous Trial (Placebo, PF-06823859)
Not yet recruiting
- Lupus Erythematosus, Systemic
- Lupus Erythematosus, Cutaneous
- Placebo
- PF-06823859
- (no location specified)
May 18, 2023
Myositis Trial in Upland, Orlando, Saint Louis (PF-06823859, Placebo)
Recruiting
- Myositis
- PF-06823859
- Placebo
-
Upland, California
- +4 more
May 29, 2023
Healthy Trial in Shinjuku-ku (PF-06823859, Placebo)
Completed
- Healthy
- PF-06823859
- Placebo
-
Shinjuku-ku, Tokyo, JapanMedical Corporation Shinanokai Shinanozaka Clinic
May 23, 2022
Healthy Trial in New Haven (PF-06823859, Placebo injection SC/IV)
Completed
- Healthy
- PF-06823859
- Placebo injection SC/IV
-
New Haven, ConnecticutPfizer New Haven Clinical Research Unit
Nov 13, 2017